Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanotubes, Carbon | 11 | 2017 | 79 | 3.560 |
Why?
|
| Endothelium, Vascular | 3 | 2013 | 237 | 1.110 |
Why?
|
| Fabaceae | 1 | 2024 | 27 | 0.940 |
Why?
|
| Cell Membrane Permeability | 3 | 2016 | 52 | 0.940 |
Why?
|
| Cell Movement | 6 | 2017 | 571 | 0.890 |
Why?
|
| Reactive Oxygen Species | 5 | 2013 | 461 | 0.770 |
Why?
|
| MicroRNAs | 2 | 2017 | 426 | 0.700 |
Why?
|
| Nanoparticles | 2 | 2016 | 318 | 0.690 |
Why?
|
| Endothelial Cells | 2 | 2013 | 308 | 0.680 |
Why?
|
| Peripheral Nerves | 1 | 2018 | 14 | 0.660 |
Why?
|
| Vibration | 1 | 2018 | 23 | 0.660 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2018 | 28 | 0.650 |
Why?
|
| Oxidative Stress | 2 | 2018 | 938 | 0.640 |
Why?
|
| Thrombospondin 1 | 1 | 2017 | 23 | 0.580 |
Why?
|
| Nanofibers | 1 | 2016 | 12 | 0.540 |
Why?
|
| Mutagens | 2 | 2018 | 69 | 0.540 |
Why?
|
| Respiratory System | 1 | 2016 | 28 | 0.540 |
Why?
|
| Comet Assay | 2 | 2012 | 76 | 0.480 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 220 | 0.480 |
Why?
|
| Lung Neoplasms | 3 | 2013 | 358 | 0.480 |
Why?
|
| Inflammation | 1 | 2018 | 618 | 0.470 |
Why?
|
| Mesenteric Arteries | 1 | 2013 | 20 | 0.460 |
Why?
|
| NF-kappa B | 3 | 2016 | 339 | 0.440 |
Why?
|
| Asbestos | 2 | 2010 | 55 | 0.430 |
Why?
|
| Gene Expression | 2 | 2017 | 674 | 0.420 |
Why?
|
| Environmental Pollutants | 4 | 2018 | 179 | 0.420 |
Why?
|
| Toxicology | 1 | 2012 | 8 | 0.410 |
Why?
|
| Transcription Factor AP-1 | 2 | 2010 | 35 | 0.410 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 88 | 0.410 |
Why?
|
| Microvessels | 1 | 2012 | 28 | 0.400 |
Why?
|
| Lung | 2 | 2012 | 446 | 0.390 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2010 | 136 | 0.390 |
Why?
|
| Drug Carriers | 1 | 2012 | 125 | 0.380 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 169 | 0.370 |
Why?
|
| Carcinogens | 2 | 2010 | 124 | 0.360 |
Why?
|
| Neoplasms, Mesothelial | 1 | 2008 | 1 | 0.330 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 269 | 0.280 |
Why?
|
| Signal Transduction | 5 | 2017 | 1908 | 0.270 |
Why?
|
| Animals | 8 | 2024 | 15081 | 0.250 |
Why?
|
| Humans | 15 | 2024 | 37093 | 0.240 |
Why?
|
| Medicine, African Traditional | 1 | 2024 | 6 | 0.240 |
Why?
|
| Plants, Medicinal | 1 | 2024 | 68 | 0.230 |
Why?
|
| Cell Line | 3 | 2016 | 1354 | 0.200 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2012 | 56 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2018 | 1618 | 0.200 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 1371 | 0.190 |
Why?
|
| Plant Extracts | 1 | 2024 | 286 | 0.190 |
Why?
|
| Chemokine CCL2 | 2 | 2012 | 85 | 0.190 |
Why?
|
| Transforming Growth Factor beta | 2 | 2016 | 197 | 0.170 |
Why?
|
| Tail | 1 | 2018 | 6 | 0.170 |
Why?
|
| Sensory Thresholds | 1 | 2018 | 12 | 0.170 |
Why?
|
| Arsenates | 1 | 2018 | 25 | 0.160 |
Why?
|
| Ganglia, Spinal | 1 | 2018 | 37 | 0.160 |
Why?
|
| Carcinogens, Environmental | 1 | 2018 | 35 | 0.160 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 70 | 0.160 |
Why?
|
| Occupational Diseases | 1 | 2018 | 47 | 0.160 |
Why?
|
| Arsenites | 1 | 2018 | 51 | 0.160 |
Why?
|
| Spinal Cord | 1 | 2018 | 94 | 0.160 |
Why?
|
| Risk Assessment | 2 | 2012 | 753 | 0.150 |
Why?
|
| DNA | 2 | 2012 | 574 | 0.150 |
Why?
|
| Male | 7 | 2018 | 20025 | 0.150 |
Why?
|
| Cell Size | 1 | 2017 | 44 | 0.140 |
Why?
|
| DNA Damage | 2 | 2010 | 352 | 0.140 |
Why?
|
| Collagen Type III | 1 | 2016 | 8 | 0.140 |
Why?
|
| Matrix Metalloproteinases | 1 | 2016 | 48 | 0.130 |
Why?
|
| Inhalation Exposure | 2 | 2013 | 43 | 0.130 |
Why?
|
| Wound Healing | 1 | 2016 | 70 | 0.130 |
Why?
|
| Rats | 2 | 2013 | 3483 | 0.130 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2013 | 146 | 0.130 |
Why?
|
| Diethylhexyl Phthalate | 1 | 2014 | 4 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2018 | 400 | 0.120 |
Why?
|
| Computational Biology | 2 | 2013 | 293 | 0.120 |
Why?
|
| Calcium-Binding Proteins | 1 | 2014 | 76 | 0.120 |
Why?
|
| Myography | 1 | 2013 | 2 | 0.120 |
Why?
|
| Amidohydrolases | 1 | 2013 | 11 | 0.120 |
Why?
|
| Nephrectomy | 1 | 2013 | 23 | 0.110 |
Why?
|
| Prognosis | 2 | 2013 | 739 | 0.110 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2013 | 12 | 0.110 |
Why?
|
| Vasodilator Agents | 1 | 2013 | 56 | 0.110 |
Why?
|
| Glioblastoma | 1 | 2014 | 55 | 0.110 |
Why?
|
| Acetylcholine | 1 | 2013 | 73 | 0.110 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2013 | 21 | 0.110 |
Why?
|
| Pulmonary Fibrosis | 1 | 2013 | 31 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2013 | 67 | 0.110 |
Why?
|
| GTPase-Activating Proteins | 1 | 2013 | 29 | 0.110 |
Why?
|
| Vasodilation | 1 | 2013 | 65 | 0.110 |
Why?
|
| DNA Helicases | 1 | 2013 | 41 | 0.110 |
Why?
|
| Arginine | 1 | 2013 | 73 | 0.110 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 111 | 0.110 |
Why?
|
| Epithelial Cells | 2 | 2013 | 384 | 0.110 |
Why?
|
| Cells, Cultured | 3 | 2013 | 1518 | 0.110 |
Why?
|
| Respiratory Mucosa | 1 | 2013 | 43 | 0.110 |
Why?
|
| Pneumonia | 1 | 2013 | 54 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 3 | 2013 | 1609 | 0.110 |
Why?
|
| Aorta | 1 | 2013 | 167 | 0.110 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 213 | 0.100 |
Why?
|
| Alkalies | 1 | 2012 | 5 | 0.100 |
Why?
|
| Electric Impedance | 1 | 2012 | 25 | 0.100 |
Why?
|
| Cell Line, Tumor | 3 | 2014 | 2231 | 0.100 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 219 | 0.100 |
Why?
|
| Phagocytosis | 1 | 2012 | 69 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 194 | 0.100 |
Why?
|
| Nuclear Proteins | 1 | 2013 | 307 | 0.100 |
Why?
|
| Enzyme Activation | 2 | 2009 | 444 | 0.090 |
Why?
|
| Occupational Exposure | 1 | 2011 | 79 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2011 | 120 | 0.090 |
Why?
|
| Carcinoma, Bronchogenic | 1 | 2010 | 1 | 0.090 |
Why?
|
| Kinetics | 1 | 2012 | 708 | 0.090 |
Why?
|
| Epithelium | 1 | 2010 | 79 | 0.090 |
Why?
|
| Silicon Dioxide | 1 | 2009 | 34 | 0.090 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2009 | 35 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2013 | 517 | 0.090 |
Why?
|
| Titanium | 1 | 2009 | 36 | 0.090 |
Why?
|
| Particle Size | 1 | 2010 | 215 | 0.080 |
Why?
|
| Mesothelioma | 1 | 2010 | 144 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 807 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 1 | 2008 | 502 | 0.070 |
Why?
|
| Histones | 1 | 2008 | 190 | 0.070 |
Why?
|
| Mice | 3 | 2013 | 5913 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2008 | 859 | 0.070 |
Why?
|
| Phosphorylation | 1 | 2008 | 928 | 0.060 |
Why?
|
| Osteoblasts | 1 | 2003 | 35 | 0.060 |
Why?
|
| Dinoprostone | 1 | 2003 | 63 | 0.060 |
Why?
|
| Estradiol | 1 | 2003 | 262 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 356 | 0.050 |
Why?
|
| Neoplasms | 1 | 2009 | 1103 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 626 | 0.040 |
Why?
|
| Biotransformation | 1 | 2018 | 67 | 0.040 |
Why?
|
| Female | 3 | 2013 | 20969 | 0.040 |
Why?
|
| Lentivirus | 1 | 2014 | 21 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 173 | 0.030 |
Why?
|
| Markov Chains | 1 | 2013 | 35 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2013 | 56 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2014 | 151 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2013 | 57 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 172 | 0.030 |
Why?
|
| Surface Properties | 1 | 2013 | 130 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 218 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2012 | 20 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 448 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2012 | 70 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 275 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 400 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 333 | 0.020 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2009 | 39 | 0.020 |
Why?
|
| Caspases | 1 | 2009 | 147 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1198 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 1492 | 0.020 |
Why?
|
| Apoptosis | 1 | 2014 | 1398 | 0.020 |
Why?
|
| Aged | 2 | 2012 | 6741 | 0.020 |
Why?
|
| Cell Survival | 1 | 2009 | 864 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2012 | 2026 | 0.020 |
Why?
|
| Middle Aged | 2 | 2012 | 10129 | 0.010 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2003 | 15 | 0.010 |
Why?
|
| Estrogen Antagonists | 1 | 2003 | 28 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2003 | 98 | 0.010 |
Why?
|
| Adult | 2 | 2012 | 11712 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 515 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 623 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 1207 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2003 | 2379 | 0.010 |
Why?
|